Altria (MO) Trades at Notable Valuation Discount Amid Strong Monthly Performance

Altria Group (NYSE: MO) shares have gained nearly 9.6% over the past month, outperforming both the tobacco industry and broader market benchmarks. This uptick comes as the stock trades at a meaningful valuation discount, offering a compelling entry point for value-minded investors as of mid-September 2026.

According to Zacks Investment Research, Altria’s forward 12-month price-to-earnings (P/E) ratio sits at approximately 12.1x. This valuation is notably lower than the tobacco industry average of 15.47x, the Consumer Staples sector average of 16.95x, and the S&P 500 average near 19.65x.

The stock’s recent performance reinforces its appeal: a 9.6% gain over the past month stands in contrast to the broader industry’s 5.1% gain, the sector’s modest 0.9% rise, and the S&P 500’s 1.8% decline during the same period.

This momentum has been supported by underlying business fundamentals. In the second quarter of 2026, Altria reported adjusted EPS of $1.48, marking a 2.8% year-over-year increase. That resilience came amid declining cigarette shipments, thanks in part to disciplined pricing strategies and portfolio management across both traditional and smoke-free products.

The company’s expansion of its smoke-free segments continues to progress. Its on! PLUS nicotine pouches have been rolled out to 120,000 stores nationwide, with further flavor and strength extensions planned for later in the year. Additionally, innovations in its traditional tobacco labels, such as Marlboro Cowboy Cut and the Basic brand, are helping support margins and offset some volume declines.

Technically, Altria is demonstrating strength. As of the latest data, the share price is trading above both its 50-day and 200-day moving averages, signaling a positive trend in investor sentiment.

Still, challenges remain. Cigarette shipment volumes dropped approximately 3.2% year-over-year in Q2, or 4.5% when adjusted for trade inventory. The oral tobacco segment saw a more significant decline, with net revenues down 5.3% and adjusted operating income (OCI) sliding 8%. These dynamics underscore the urgency of Altria’s shift toward smoke-free offerings.

Stock snapshot: As of September 17, 2026, Altria’s share price stands at $69.70, reflecting a modest intraday decline. While trailing and forward returns vary across sources, data indicates substantial longer-term outperformance; YTD returns are around 26–32%, depending on the timeframe, compared with the S&P 500.

Among analysts, opinion remains split. UBS maintains a “Buy” rating with a $79 price target, while Barclays holds a more cautious stance with a lower valuation range.

Bottom line: Altria currently trades at a discounted valuation relative to its peers and broader indices, backed by resilient Q2 earnings and strategic product evolution. Its recent price momentum, combined with strong dividend support, makes it an attractive proposition for investors favoring income with value orientation. However, ongoing volume declines and execution risk in its smoke-free transition tempers near-term upside potential.